Bayer Wants Shareholder Suit Separate From Roundup MDL
Law360 (July 28, 2020, 3:16 PM EDT) -- Bayer is urging a California federal court not to allow pension fund claims that it downplayed the significance of litigation over the weedkiller Roundup into wider multidistrict litigation involving claims that it causes non-Hodgkin's lymphoma, saying the disputes have "no meaningful overlap."
Bayer AG told the court Monday that even suits claiming the weedkiller causes cancers besides non-Hodgkin's lymphoma have been excluded from the MDL, so a shareholder suit against Bayer and its leadership definitely doesn't have enough in common with personal injury claims against Monsanto to warrant tying the two together.
"If cases that involve the common backdrop of alleged use of...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!